PRODUCTS 产品服务
invivoCrown IV0103替换BioXCell BE0075-1

invivoCrown IV0103替换BioXCell BE0075-1

InVivoPro Anti-Mouse Ly6G in vivo antibody, Clone 1A8 ...

invivoCrown IV0108替换BioXCell BE0034

invivoCrown IV0108替换BioXCell BE0034

InVivoPro Anti-Mouse LPAM-1 (Integrin α4β7) in vivo antibody, Clone DATK32 ...

invivoCrown IV0104替换BioXCell BE0061

invivoCrown IV0104替换BioXCell BE0061

InVivoPro Anti-Mouse CD8α in vivo antibody, Clone 2.43 ...

invivoCrown IV0116替换BioXCell BE0016-2

invivoCrown IV0116替换BioXCell BE0016-2

InVivoPro Anti-Mouse CD40 in vivo antibody, Clone FGK45 ...

ABOUT US
艾美捷科技,作为国际知名供应商在中国区10年以上的金牌代理商和独家代理商,是中国国内最早提出专注和专业服务于科研经销商,为经销商伙伴提供一站式服务(科研类订单转介绍/当地市场分析/销售团队组建/各个区域品牌代理授权/技术售前和售后/市场营销资料共享/供应商合作开发)的密切合作伙伴。 艾美捷科
NEWS 新闻中心
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品 ">
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品 ">
艾美捷官网上传1:1.jpgexocell.jpg

艾美捷科技代理NeXtal Biotechnologies品牌。

NeXtal Biotechnologies 是一家专注于为结构生物学和药物发现领域提供高质量试剂、耗材和工具的公司。公司致力于支持科学家在蛋白质晶体学、小分子晶体学和药物筛选等领域的研究,提供从蛋白质纯化到晶体生长的全流程解决方案。NeXtal Biotechnologies核心业务领域:

(1)蛋白质纯化工具:NeXtal Biotechnologies 提供用于蛋白质纯化的工具和试剂,如亲和层析柱、蛋白质浓缩器和透析设备。

(2)晶体生长试剂:公司提供多种用于蛋白质和小分子晶体生长的试剂,包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。

(3)结晶筛选试剂盒:NeXtal Biotechnologies 提供多种结晶筛选试剂盒,如 JCSG+、Morpheus 和 PACT,适用于不同类型的晶体生长实验。

(4)晶体学耗材:提供用于晶体学研究的耗材,如结晶板、密封膜、样品支架和低温冷冻工具。这些耗材与主流X射线衍射仪兼容,支持从晶体生长到数据收集的全流程。

(5)自动化晶体成像系统:NeXtal Biotechnologies 提供自动化晶体成像系统(如 Rock Imager),用于实时监测晶体生长过程,帮助科学家优化晶体生长条件。

(6)药物筛选工具:公司提供用于药物筛选的工具和试剂,如蛋白质-配体结合分析试剂盒和高通量筛选板。



< " alt="艾美捷科技代理NeXtal Biotechnologies品牌 ">